ifosfamide has been researched along with Liver Neoplasms in 85 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This Phase II trial of paclitaxel/ifosfamide included patients with bi-dimensionally measurable metastatic breast cancer in second or third relapse, following anthracycline-containing regimens; ECOG PS < 2, and adequate hepatic, cardiac, renal, and hematological functions." | 9.08 | Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer. ( Amorim, WC; Ferreira-Filho, AF; Guimaraes, RC; Morici, AC; Murad, AM; Schwartsmann, G, 1997) |
| "This Phase I/II study investigates increasingly high doses of ifosfamide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in patients with metastatic soft tissue sarcoma (STS)." | 9.08 | A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. ( Arseniev, L; Bokemeyer, C; Franzke, A; Hartmann, JT; Kanz, L; Link, H; Metzner, B; Schmoll, HJ; Schöber, C, 1997) |
| "The Cooperative German Paediatric Liver Tumour Study HB89 was conceived to evaluate the efficiency and toxicity of ifosfamide, cisplatin and doxorubicin (IPA) in children with resectable and non-resectable hepatoblastoma (HB) and to determine late sequelae including tubular nephropathy of tumour treatment." | 9.08 | Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. ( Bode, U; Bürger, D; Byrd, DJ; Erttmann, R; Harms, D; Hecker, H; Mildenberger, H; von Schweinitz, D; Weinel, P, 1997) |
| "A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients." | 9.07 | Phase II study of high-dose ifosfamide in hepatocellular carcinoma. ( Lau, WY; Leung, N; Leung, WT; Li, AK; Lin, J; Shiu, W; Tao, M, 1993) |
| "This case shows us that operation on late stage cardiac angiosarcomas can alleviate a patient's symptoms; postoperative paclitaxel monotherapy was insufficient and ifosfamide and epirubicin plus recombinant human endostatin has a limited effect on late stage cardiac angiosarcoma." | 7.91 | The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. ( Davies, H; Jiang, L; Shi, K; Xu, X, 2019) |
| "We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide." | 7.70 | [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide]. ( Fujinami, K; Kondoh, I; Kondoh, K; Kushida, K; Miura, T, 1999) |
| "A total of 51 fully evaluable patients with advanced and intensively pretreated breast cancer were treated with a combination chemotherapy of ifosfamide plus mesna, methotrexate and 5-fluorouracil." | 7.68 | Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer. ( Becher, R; Höfeler, H; Kloke, O; May, D; Niederle, N; Richter, R; Scheulen, ME; Schmidt, CG; Wandl, U, 1991) |
| "Hepatoblastoma is the most common primary malignant liver tumor affecting infants and young children." | 5.30 | Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. ( Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M, 1998) |
| "Chemotherapy for liver metastasis of breast cancer has rarely been found effective." | 5.28 | [Clinical efficacy of ifosfamide for liver metastasis of breast cancer]. ( Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y, 1990) |
| "The European Organization for Research and Treatment of Cancer (EORTC) 62012 study was a Phase III trial of doxorubicin versus doxorubicin-ifosfamide chemotherapy in 455 patients with advanced soft tissue sarcoma (STS)." | 5.24 | Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study. ( Collin, F; Daugaard, S; Fisher, C; Gronchi, A; Grünwald, V; Hogendoorn, PCW; Judson, I; Lia, M; Litière, S; Mechtersheimer, G; Messiou, C; Sciot, R; van der Graaf, W; Wardelmann, E; Young, RJ, 2017) |
| "The Cooperative German Paediatric Liver Tumour Study HB89 was conceived to evaluate the efficiency and toxicity of ifosfamide, cisplatin and doxorubicin (IPA) in children with resectable and non-resectable hepatoblastoma (HB) and to determine late sequelae including tubular nephropathy of tumour treatment." | 5.08 | Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology. ( Bode, U; Bürger, D; Byrd, DJ; Erttmann, R; Harms, D; Hecker, H; Mildenberger, H; von Schweinitz, D; Weinel, P, 1997) |
| "This Phase II trial of paclitaxel/ifosfamide included patients with bi-dimensionally measurable metastatic breast cancer in second or third relapse, following anthracycline-containing regimens; ECOG PS < 2, and adequate hepatic, cardiac, renal, and hematological functions." | 5.08 | Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer. ( Amorim, WC; Ferreira-Filho, AF; Guimaraes, RC; Morici, AC; Murad, AM; Schwartsmann, G, 1997) |
| "This Phase I/II study investigates increasingly high doses of ifosfamide combined with full dose doxorubicin chemotherapy supported with peripheral blood stem cells (PBSC) and granulocyte-colony stimulating factor (G-CSF) in patients with metastatic soft tissue sarcoma (STS)." | 5.08 | A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. ( Arseniev, L; Bokemeyer, C; Franzke, A; Hartmann, JT; Kanz, L; Link, H; Metzner, B; Schmoll, HJ; Schöber, C, 1997) |
| "A phase II study of high-dose ifosfamide in hepatocellular carcinoma was conducted among 17 Chinese patients." | 5.07 | Phase II study of high-dose ifosfamide in hepatocellular carcinoma. ( Lau, WY; Leung, N; Leung, WT; Li, AK; Lin, J; Shiu, W; Tao, M, 1993) |
| "This case shows us that operation on late stage cardiac angiosarcomas can alleviate a patient's symptoms; postoperative paclitaxel monotherapy was insufficient and ifosfamide and epirubicin plus recombinant human endostatin has a limited effect on late stage cardiac angiosarcoma." | 3.91 | The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report. ( Davies, H; Jiang, L; Shi, K; Xu, X, 2019) |
| "The purpose of the German HB99 trial (1999-2008) for hepatoblastoma (HB), was primarily to analyse the effect of high dose (HD) chemotherapy with carboplatin/etoposide (CE) in high risk (HR) patients with extended tumors, vessel involvement, extrahepatic tumor or distant metastases." | 3.91 | High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99. ( Häberle, B; Maxwell, R; Schmid, I; Schweinitz, DV, 2019) |
| "To evaluate the efficacy and safety of the ICE regimen (iphosphamide + carboplatin + etoposide) used in treating children with hepatoblastoma in the Shanghai Children's Medical Center." | 3.75 | [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center]. ( Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Xue, HL; Ye, QD; Zhou, M, 2009) |
| " Surgical biopsy performed after the first IPA (ifosfamide, cisplatin, doxorubicin) course showed hepatoblastoma with macrotrabecular variant." | 3.73 | Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol. ( Anik, Y; Corapçioğlu, F; Sarper, N; Tugay, M; Ural, D; Yildiz, K, 2006) |
| "We report a case of retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide." | 3.70 | [A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide]. ( Fujinami, K; Kondoh, I; Kondoh, K; Kushida, K; Miura, T, 1999) |
| "A total of 51 fully evaluable patients with advanced and intensively pretreated breast cancer were treated with a combination chemotherapy of ifosfamide plus mesna, methotrexate and 5-fluorouracil." | 3.68 | Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer. ( Becher, R; Höfeler, H; Kloke, O; May, D; Niederle, N; Richter, R; Scheulen, ME; Schmidt, CG; Wandl, U, 1991) |
| "Infantile choriocarcinoma has a poor prognosis with only 2 surviving children reported in the literature." | 2.41 | Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection. ( Ambros, PF; Blohm, ME; Bolkenius, M; Calaminus, G; Gnekow, AK; Göbel, U; Harms, D; Heidemann, PH; Schneider, DT; von Schweinitz, D; Weinel, P, 2001) |
| "The Barcelona Clinic Liver Cancer (BCLC) staging system is commonly used to classify hepatocellular carcinoma (HCC) patients." | 1.56 | Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients. ( Czauderna, C; Galle, PR; Heil, E; Heinrich, B; Heinrich, S; Kloeckner, R; Koch, S; Marquardt, JU; Philippe P Diggs, L; Schmidtmann, I; Sprinzl, M; Weinmann, A; Wörns, MA, 2020) |
| "Hepatic angiosarcoma is an extremely rare diagnosis in children, with fewer than 50 pediatric cases reported in the literature worldwide." | 1.51 | Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report. ( Chinnakotla, S; Eidenschink, B; Luquette, M; Neglia, J; Pilbeam, K; Sulciner, M, 2019) |
| "Adult extrarenal nephroblastomas (Wilms' tumor) are extremely rare tumors." | 1.37 | The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component. ( Aksu, C; Başaran, M; Bavbek, S; Ekenel, M; Keskin, S; Kiliçaslan, I; Tunç, M, 2011) |
| "A primitive neuroectodermal tumor (PNET) is a small round cell tumor that arises from the nerve crest." | 1.36 | Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin. ( Horiuchi, K; Kondo, Y; Mizutani, S; Ohgaki, K; Sato, M, 2010) |
| "The response of adult soft tissue sarcoma (STS) to chemotherapy is uncertain." | 1.34 | [Responses of 109 adult soft tissue sarcoma patients to chemotherapy]. ( Guan, ZZ; Huang, HQ; Jiang, WQ; Li, FH; Lin, TY; Luo, HY; Qiu, MZ; Sun, XF; Wang, F; Wang, SS; Xu, F; Xu, GC; Xu, RH, 2007) |
| "Angiosarcomas are rare soft tissue malignancies." | 1.33 | Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature. ( Bearz, A; Berretta, M; Berretta, S; Brollo, A; Buonadonna, A; Canzonieri, V; Frustaci, S; Morra, A; Rupolo, M; Tirelli, U, 2006) |
| "Congenital mesoblastic nephroma was originally considered to be a benign neoplasm." | 1.32 | Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases. ( Hitchcock, RJ; Mitchell, CD; Patel, Y, 2003) |
| "Our 35-year-old patient had atypical carcinoid tumor metastatic to cervical, supraclavicular, mediastinal, and mesenteric lymph nodes and to the liver and bone." | 1.31 | High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor. ( Anthony, LB; Drouant, G; Espanan, GD; Maloney, TJ; McCarthy, KE; Meyers, MO; Woltering, EA, 2000) |
| "In patients with metastatic breast cancer (MBC), early dose intensification with multiple cycles of peripheral blood stem cell-supported high-dose chemotherapy (HDCT) seems superior to a late dose-intensification strategy." | 1.31 | Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer. ( Bastert, G; Egerer, G; Goerner, R; Grischke, EM; Haas, R; Hensel, M; Ho, AD; Hohaus, S; Khbeis, T; Schneeweiss, A; Solomayer, E, 2001) |
| "Primary hepatic lymphoma is rare malignancy." | 1.31 | Cure in a case of primary hepatic lymphoma. ( Aggarwal, S; Arora, A; Bhalla, S; Murthy, SA; Singh, B; Vohra, R, 2000) |
| "Hepatoblastoma is the most common primary malignant liver tumor affecting infants and young children." | 1.30 | Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma. ( Fuchs, J; Haindl, J; Leuschner, I; von Schweinitz, D; Wenderoth, M, 1998) |
| "The patient died due to brain metastases 20 months after the start of intra-arterial chemotherapy." | 1.30 | [A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port]. ( Hasegawa, N; Kazama, A; Kondo, N; Tomita, M, 1999) |
| "11 months later brain metastases were diagnosed." | 1.29 | Undifferentiated (embryonal) sarcoma of the liver in an adult patient with metastasis of the heart and brain. ( Fehske, W; Fischer, HP; Hartlapp, JH; Reichel, C, 1994) |
| "Chemotherapy for liver metastasis of breast cancer has rarely been found effective." | 1.28 | [Clinical efficacy of ifosfamide for liver metastasis of breast cancer]. ( Ando, K; Funahashi, H; Imai, T; Kato, M; Kato, N; Narita, T; Odaka, K; Oike, E; Ono, M; Sato, Y, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (4.71) | 18.7374 |
| 1990's | 24 (28.24) | 18.2507 |
| 2000's | 28 (32.94) | 29.6817 |
| 2010's | 22 (25.88) | 24.3611 |
| 2020's | 7 (8.24) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, H | 1 |
| Zhang, W | 1 |
| Zhang, Y | 1 |
| Gao, Y | 1 |
| Zhi, T | 1 |
| Li, F | 1 |
| Li, J | 1 |
| Gu, H | 1 |
| Liao, R | 1 |
| Wu, R | 1 |
| Huang, D | 1 |
| Häberle, B | 1 |
| Maxwell, R | 1 |
| Schweinitz, DV | 1 |
| Schmid, I | 1 |
| Yonemaru, J | 1 |
| Takahashi, M | 2 |
| Nara, S | 1 |
| Ichikawa, H | 1 |
| Ishigamori, R | 1 |
| Imai, T | 2 |
| Hiraoka, N | 1 |
| Heinrich, S | 1 |
| Sprinzl, M | 1 |
| Schmidtmann, I | 1 |
| Heil, E | 1 |
| Koch, S | 1 |
| Czauderna, C | 1 |
| Heinrich, B | 1 |
| Philippe P Diggs, L | 1 |
| Wörns, MA | 1 |
| Kloeckner, R | 1 |
| Galle, PR | 1 |
| Marquardt, JU | 1 |
| Weinmann, A | 1 |
| Lauhan, CR | 1 |
| Schiff, D | 1 |
| Gloude, N | 1 |
| Sjoberg Bexelius, T | 1 |
| Chisholm, JC | 1 |
| Okoye, B | 1 |
| Cecil, T | 1 |
| Angelini, P | 1 |
| Dayal, S | 1 |
| Ahmed, DE | 1 |
| Rashidi, FB | 1 |
| Abdelhakim, HK | 1 |
| Mohamed, AS | 1 |
| Arafa, HMM | 1 |
| Young, RJ | 1 |
| Litière, S | 1 |
| Lia, M | 1 |
| Hogendoorn, PCW | 1 |
| Fisher, C | 1 |
| Mechtersheimer, G | 1 |
| Daugaard, S | 1 |
| Sciot, R | 1 |
| Collin, F | 1 |
| Messiou, C | 1 |
| Grünwald, V | 1 |
| Gronchi, A | 1 |
| van der Graaf, W | 1 |
| Wardelmann, E | 1 |
| Judson, I | 2 |
| Patrono, D | 1 |
| Paraluppi, G | 1 |
| Romagnoli, R | 1 |
| Kurita, D | 1 |
| Mokuno, Y | 1 |
| Matsubara, H | 1 |
| Kaneko, H | 1 |
| Shamoto, M | 1 |
| Satou, A | 1 |
| Iyomasa, S | 1 |
| Ter-Ovanesov, MD | 1 |
| Valkin, DL | 1 |
| Gaboyan, AS | 1 |
| Kukosh, MY | 1 |
| Ronzin, AV | 1 |
| Andrianova, VS | 1 |
| Larin, AL | 1 |
| Zhuk, AI | 1 |
| Pilbeam, K | 1 |
| Eidenschink, B | 1 |
| Sulciner, M | 1 |
| Luquette, M | 1 |
| Neglia, J | 1 |
| Chinnakotla, S | 1 |
| Jiang, L | 1 |
| Xu, X | 1 |
| Davies, H | 1 |
| Shi, K | 1 |
| Natarajan, E | 1 |
| Auerbach, C | 1 |
| Cheron, R | 1 |
| Pashankar, F | 1 |
| Scheppach, W | 1 |
| Reissmann, N | 1 |
| Sprinz, T | 1 |
| Schippers, E | 1 |
| Schoettker, B | 1 |
| Mueller, JG | 1 |
| Chocarro, G | 1 |
| Amesty, MV | 1 |
| Hernández, F | 1 |
| Chenu, BG | 1 |
| Ortíz, R | 1 |
| Hernández, S | 1 |
| Sánchez, A | 1 |
| Gámez, M | 1 |
| Santamaría, ML | 1 |
| Tovar, JA | 1 |
| Miolo, G | 1 |
| Viel, A | 1 |
| Canzonieri, V | 2 |
| Baresic, T | 1 |
| Buonadonna, A | 2 |
| Santeufemia, DA | 1 |
| Lara, DP | 1 |
| Corona, G | 1 |
| Hiyama, E | 2 |
| Hishiki, T | 2 |
| Watanabe, K | 2 |
| Ida, K | 2 |
| Yano, M | 2 |
| Oue, T | 2 |
| Iehara, T | 1 |
| Hoshino, K | 1 |
| Koh, K | 1 |
| Tanaka, Y | 1 |
| Kurihara, S | 1 |
| Ueda, Y | 1 |
| Onitake, Y | 1 |
| Pagliaro, LC | 1 |
| Wei, ZG | 1 |
| Tang, LF | 1 |
| Chen, ZM | 1 |
| Tang, HF | 1 |
| Li, MJ | 1 |
| Gutweiler, JR | 1 |
| Yu, DC | 1 |
| Kim, HB | 1 |
| Kozakewich, HP | 1 |
| Marcus, KJ | 1 |
| Shamberger, RC | 1 |
| Weldon, CB | 1 |
| Pintoffl, J | 1 |
| Meisinger, I | 1 |
| Mayer, F | 1 |
| Horger, M | 1 |
| von Weyhern, C | 1 |
| Kanz, L | 2 |
| Hartmann, JT | 2 |
| Al Balushi, Z | 1 |
| Bulduc, S | 1 |
| Mulleur, C | 1 |
| Lallier, M | 1 |
| Pan, C | 1 |
| Tang, JY | 1 |
| Chen, J | 1 |
| Xue, HL | 1 |
| Dong, L | 1 |
| Zhou, M | 1 |
| Jiang, H | 1 |
| Ye, QD | 1 |
| Gu, LJ | 1 |
| Ohgaki, K | 1 |
| Horiuchi, K | 1 |
| Mizutani, S | 1 |
| Sato, M | 1 |
| Kondo, Y | 1 |
| Nagai, Y | 1 |
| Ikegame, K | 1 |
| Mori, M | 1 |
| Inoue, D | 1 |
| Kimura, T | 1 |
| Shimoji, S | 1 |
| Togami, K | 1 |
| Tabata, S | 1 |
| Kurata, M | 1 |
| Imai, Y | 1 |
| Matsushita, A | 1 |
| Nagai, K | 1 |
| Ogawa, H | 1 |
| Takahashi, T | 1 |
| Xing, PY | 1 |
| Shi, YK | 1 |
| Feng, FY | 1 |
| Qin, Y | 1 |
| Liu, P | 1 |
| Lindet, C | 1 |
| Vanhuyse, M | 1 |
| Thebaud, E | 1 |
| Robin, YM | 1 |
| Penel, N | 1 |
| Matsunaga, T | 1 |
| Sasaki, F | 1 |
| Horie, H | 1 |
| Kondo, S | 1 |
| Tajiri, T | 1 |
| Kamimatsuse, A | 1 |
| Ohnuma, N | 1 |
| Keskin, S | 1 |
| Ekenel, M | 1 |
| Başaran, M | 1 |
| Aksu, C | 1 |
| Kiliçaslan, I | 1 |
| Tunç, M | 1 |
| Bavbek, S | 1 |
| Oral, A | 1 |
| Yigiter, M | 1 |
| Demirci, E | 1 |
| Yildirim, ZK | 1 |
| Kantarci, M | 1 |
| Salman, AB | 1 |
| Richey, SL | 1 |
| Rao, P | 1 |
| Wood, CG | 1 |
| Patel, S | 1 |
| Tannir, NM | 1 |
| Dede, DS | 1 |
| Aksoy, S | 1 |
| Cengiz, M | 1 |
| Gullu, I | 1 |
| Altundag, K | 1 |
| Kuperman, AA | 1 |
| Kornreich, L | 1 |
| Feinmesser, M | 1 |
| Ash, S | 1 |
| Yaniv, I | 1 |
| Cohen, IJ | 1 |
| Fuchs, J | 2 |
| Rydzynski, J | 1 |
| Hecker, H | 2 |
| Mildenberger, H | 2 |
| Bürger, D | 2 |
| Harms, D | 4 |
| V Schweinitz, D | 1 |
| Dalpiaz, O | 1 |
| al Rabi, N | 1 |
| Galfano, A | 1 |
| Martignoni, G | 1 |
| Ficarra, V | 1 |
| Artibani, W | 1 |
| Patel, Y | 1 |
| Mitchell, CD | 1 |
| Hitchcock, RJ | 1 |
| Ishizuka, O | 1 |
| Satoh, T | 1 |
| Mizuno, H | 1 |
| Mizusawa, H | 1 |
| Seki, S | 1 |
| Nishizawa, O | 1 |
| Sharif, K | 1 |
| English, M | 1 |
| Ramani, P | 1 |
| Alberti, D | 1 |
| Otte, JB | 1 |
| McKiernan, P | 1 |
| Gosseye, S | 1 |
| Jenney, M | 1 |
| de Ville de Goyet, J | 1 |
| Zhu-Ge, J | 1 |
| Yu, YN | 1 |
| Dillman, RO | 1 |
| Barth, NM | 1 |
| VanderMolen, LA | 1 |
| Allen, K | 1 |
| Beutel, LD | 1 |
| Chico, S | 1 |
| Zak, D | 1 |
| Styler, MJ | 1 |
| Rosenbluth, JZ | 1 |
| Brodsky, I | 1 |
| Berretta, M | 1 |
| Rupolo, M | 1 |
| Brollo, A | 1 |
| Morra, A | 1 |
| Berretta, S | 1 |
| Bearz, A | 1 |
| Tirelli, U | 1 |
| Frustaci, S | 1 |
| Sarper, N | 1 |
| Corapçioğlu, F | 1 |
| Anik, Y | 1 |
| Ural, D | 1 |
| Yildiz, K | 1 |
| Tugay, M | 1 |
| Antonelli, A | 1 |
| Simeone, C | 1 |
| Ferrari, V | 1 |
| Tardanico, R | 1 |
| Cunico, SC | 1 |
| Kawai, K | 1 |
| Takaoka, E | 1 |
| Naoi, M | 1 |
| Mori, K | 1 |
| Minami, M | 1 |
| Shimazui, T | 1 |
| Akaza, H | 1 |
| Li, EX | 1 |
| Zhang, YT | 1 |
| Shang, JT | 1 |
| Xu, Z | 1 |
| Geng, Y | 1 |
| Li, SM | 1 |
| Shi, F | 1 |
| Wu, YY | 1 |
| Harada, A | 1 |
| Yamamoto, Y | 1 |
| Taue, R | 1 |
| Kishimoto, T | 1 |
| Tanimoto, S | 1 |
| Izaki, H | 1 |
| Fukumori, T | 1 |
| Nishitani, MA | 1 |
| Kanayama, HO | 1 |
| Hayashi, H | 1 |
| Kim, KT | 1 |
| Han, SY | 1 |
| Park, EH | 1 |
| Jang, JS | 1 |
| Roh, MH | 1 |
| Lee, SW | 1 |
| Jeong, JS | 1 |
| Qiu, MZ | 1 |
| Xu, F | 1 |
| Wang, SS | 1 |
| Luo, HY | 1 |
| Wang, F | 1 |
| Li, FH | 1 |
| Sun, XF | 1 |
| Xu, GC | 1 |
| Lin, TY | 1 |
| Huang, HQ | 1 |
| Jiang, WQ | 1 |
| Guan, ZZ | 1 |
| Xu, RH | 1 |
| Mantadakis, E | 1 |
| Raissaki, M | 1 |
| Tzardi, M | 1 |
| Katzilakis, N | 1 |
| Chatzimichael, A | 1 |
| Kalmanti, M | 1 |
| Kehl, A | 1 |
| Bergholz, M | 1 |
| von Heyden, HW | 1 |
| Nagel, GA | 1 |
| Kattan, J | 1 |
| Culine, S | 1 |
| Theodore, C | 1 |
| Droz, JP | 1 |
| Wessalowski, R | 1 |
| Spaar, HJ | 1 |
| Pape, H | 1 |
| Willers, R | 1 |
| Göbel, U | 2 |
| Reichel, C | 1 |
| Fehske, W | 1 |
| Fischer, HP | 1 |
| Hartlapp, JH | 1 |
| Devalck, C | 1 |
| Tempels, D | 1 |
| Ferster, A | 1 |
| De Laet, MH | 1 |
| Bujan, W | 1 |
| Heiman, P | 1 |
| Sariban, E | 1 |
| Lin, J | 1 |
| Shiu, W | 1 |
| Leung, WT | 1 |
| Tao, M | 1 |
| Leung, N | 1 |
| Lau, WY | 1 |
| Li, AK | 1 |
| Roman, LD | 1 |
| Mitchell, MF | 1 |
| Tornos, C | 1 |
| Glover, A | 1 |
| Kavanagh, JJ | 1 |
| Gururangan, S | 1 |
| Bowman, LC | 1 |
| Parham, DM | 1 |
| Wilimas, JA | 1 |
| Rao, B | 1 |
| Pratt, CB | 1 |
| Douglass, EC | 1 |
| Gunawardena, SW | 1 |
| Trautwein, LM | 1 |
| Finegold, MJ | 1 |
| Ogden, AK | 1 |
| Malik, IA | 1 |
| Khan, WA | 1 |
| Haq, S | 1 |
| Sabih, M | 1 |
| Murad, AM | 1 |
| Guimaraes, RC | 1 |
| Amorim, WC | 1 |
| Morici, AC | 1 |
| Ferreira-Filho, AF | 1 |
| Schwartsmann, G | 1 |
| von Schweinitz, D | 3 |
| Byrd, DJ | 1 |
| Weinel, P | 2 |
| Bode, U | 1 |
| Erttmann, R | 1 |
| Bokemeyer, C | 1 |
| Franzke, A | 1 |
| Schöber, C | 1 |
| Arseniev, L | 1 |
| Metzner, B | 1 |
| Link, H | 1 |
| Schmoll, HJ | 1 |
| Chou, CW | 1 |
| Liu, JM | 1 |
| Wu, MF | 1 |
| Li, AF | 1 |
| Tie, CM | 1 |
| Chi, KH | 1 |
| Wenderoth, M | 1 |
| Haindl, J | 1 |
| Leuschner, I | 1 |
| el Otmany, A | 1 |
| Bouklata, S | 1 |
| Chami, I | 1 |
| Souadka, A | 1 |
| Jahid, A | 1 |
| Belabbas, M | 1 |
| Kondo, N | 1 |
| Tomita, M | 1 |
| Hasegawa, N | 1 |
| Kazama, A | 1 |
| Fujinami, K | 1 |
| Kondoh, K | 1 |
| Kondoh, I | 1 |
| Miura, T | 1 |
| Kushida, K | 1 |
| Le Cesne, A | 1 |
| Crowther, D | 1 |
| Rodenhuis, S | 1 |
| Keizer, HJ | 1 |
| Van Hoesel, Q | 1 |
| Blay, JY | 1 |
| Frisch, J | 1 |
| Van Glabbeke, M | 1 |
| Hermans, C | 1 |
| Van Oosterom, A | 1 |
| Tursz, T | 2 |
| Verweij, J | 2 |
| Meyers, MO | 1 |
| Anthony, LB | 1 |
| McCarthy, KE | 1 |
| Drouant, G | 1 |
| Maloney, TJ | 1 |
| Espanan, GD | 1 |
| Woltering, EA | 1 |
| Tokunaga, Y | 1 |
| Ryo, J | 1 |
| Hoppou, T | 1 |
| Kitaoka, A | 1 |
| Tokuka, A | 1 |
| Osumi, K | 1 |
| Tanaka, T | 1 |
| Blohm, ME | 1 |
| Calaminus, G | 1 |
| Gnekow, AK | 1 |
| Heidemann, PH | 1 |
| Bolkenius, M | 1 |
| Ambros, PF | 1 |
| Schneider, DT | 1 |
| Schneeweiss, A | 1 |
| Hensel, M | 1 |
| Goerner, R | 1 |
| Khbeis, T | 1 |
| Hohaus, S | 1 |
| Egerer, G | 1 |
| Solomayer, E | 1 |
| Haas, R | 1 |
| Grischke, EM | 1 |
| Bastert, G | 1 |
| Ho, AD | 1 |
| Murthy, SA | 1 |
| Singh, B | 1 |
| Bhalla, S | 1 |
| Arora, A | 1 |
| Vohra, R | 1 |
| Aggarwal, S | 1 |
| Frankel, EB | 1 |
| Le Chevalier, T | 1 |
| Thomas, F | 1 |
| Subirana, R | 1 |
| Baldeyrou, P | 1 |
| Ruffie, P | 1 |
| Arriagada, R | 1 |
| Chazard, M | 1 |
| Staines, A | 1 |
| Cullen, S | 1 |
| Guiney, EJ | 1 |
| Fitzgerald, RJ | 1 |
| Breatnach, F | 1 |
| Lewis, CR | 1 |
| Fossà, SD | 1 |
| Mead, G | 1 |
| ten Bokkel Huinink, W | 1 |
| Harding, MJ | 1 |
| Mill, L | 1 |
| Paul, J | 1 |
| Jones, WG | 1 |
| Rodenburg, CJ | 1 |
| Cantwell, B | 1 |
| Becher, R | 1 |
| Höfeler, H | 1 |
| Kloke, O | 1 |
| May, D | 1 |
| Wandl, U | 1 |
| Niederle, N | 1 |
| Richter, R | 1 |
| Scheulen, ME | 1 |
| Schmidt, CG | 1 |
| Funahashi, H | 1 |
| Sato, Y | 1 |
| Kato, N | 1 |
| Ando, K | 1 |
| Oike, E | 1 |
| Odaka, K | 1 |
| Ono, M | 1 |
| Narita, T | 1 |
| Kato, M | 1 |
| Trillet, V | 1 |
| Chauvin, F | 1 |
| Champel, F | 1 |
| Bernard, JP | 1 |
| Brune, J | 1 |
| Clavel, M | 1 |
| Cordier, JF | 1 |
| Emonot, A | 1 |
| Guérin, JC | 1 |
| Kalb, JC | 1 |
| Kreuser, ED | 1 |
| Jaeger, N | 1 |
| Altwein, JE | 1 |
| Egghart, G | 1 |
| Hartlapp, J | 1 |
| Gaus, W | 1 |
| Schreml, W | 1 |
| Thongprasert, S | 1 |
| Klunklin, K | 1 |
| Phornphutkul, K | 1 |
| Prisontarangkul, OA | 1 |
| Chaimongkol, B | 1 |
| Sivasomboon, B | 1 |
| Planting, AS | 1 |
| van der Burg, ME | 1 |
| Hoff, AM | 1 |
| Stoter, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience[NCT02557750] | 35 participants (Anticipated) | Observational | 2016-01-31 | Recruiting | |||
| A Phase II Multicenter Trial of RAD001 in Patients With Metastatic or Recurrent Sarcomas[NCT01830153] | Phase 2 | 41 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft Tissue Sarcoma After Pre-treatment Failure: an Open-label, Multicenter Phase II Study[NCT01136499] | Phase 2 | 53 participants (Actual) | Interventional | 2010-01-31 | Completed | ||
| Comparing the Effectiveness and Toxicity for Locally Advanced, Unresectable or Metastatic Soft-tissue Sarcoma Patients Who Had Received Total Dose of Anthracycline Antibiotics More Than 300mg/m2 With Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus[NCT03342300] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2017-11-06 | Withdrawn (stopped due to No participants enrolled) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for ifosfamide and Liver Neoplasms
| Article | Year |
|---|---|
[Hepatic leiomyosarcoma: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Hepatectomy; Hodgkin Disease; H | 2016 |
Role of High-Dose Chemotherapy With Autologous Stem-Cell Rescue in Men With Previously Treated Germ Cell Tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2017 |
[Clinical characteristics and treatment of desmoplastic small round cell tumor].
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2010 |
Small cell carcinoma of the bladder: a case report and a literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, Small Cell; | 2003 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Mo | 2005 |
Dedifferentiated extrauterine adenosarcoma responsive to chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; | 1993 |
Hepatic undifferentiated (embryonal) sarcoma in an adult: a case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubici | 2000 |
Disseminated choriocarcinoma in infancy is curable by chemotherapy and delayed tumour resection.
Topics: Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Chromosome Aberrations; Cisplatin; | 2001 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
11 trials available for ifosfamide and Liver Neoplasms
| Article | Year |
|---|---|
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Female; Follow-U | 2017 |
High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carbo | 2005 |
Phase II trial of ifosfamide, fluorouracil, and folinic acid (FIFO regimen) in relapsed and refractory urothelial cancer.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms | 1995 |
Phase II study of high-dose ifosfamide in hepatocellular carcinoma.
Topics: Adult; Aged; Alopecia; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Female; Humans | 1993 |
A prospective phase II trial to evaluate the efficacy and toxicity of hepatic arterial infusion of ifosfamide in patients with inoperable localized hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Carcinoma, Hepatocellular; Humans; Ifosfamide; Infus | 1997 |
Phase II trial of paclitaxel and ifosfamide as a salvage treatment in metastatic breast cancer.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; F | 1997 |
Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cis | 1997 |
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doxorubicin; Granu | 1997 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the Europe
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 2000 |
BOP/VIP--a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Brain Neoplasms; Chorioni | 1991 |
[Small cell lung carcinoma. Value of the evaluation of extension for the therapeutic strategy].
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clin | 1990 |
66 other studies available for ifosfamide and Liver Neoplasms
| Article | Year |
|---|---|
Individualized chemotherapy and efficacy analysis of hepatoblastoma in children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cisplatin; Cyclophosphamide; Eto | 2024 |
High Dose Chemotherapy with Autologous Stem Cell Transplantation in Hepatoblastoma does not Improve Outcome. Results of the GPOH Study HB99.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; D | 2019 |
A yolk sac tumor of the pancreas and derived xenograft model effectively responded to VIP chemotherapy.
Topics: Adenocarcinoma; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cis | 2020 |
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic C | 2020 |
Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; | 2020 |
Hyperthermic intraperitoneal chemotherapy (HIPEC) as another treatment modality for desmoplastic round cell tumour patients: first paediatric experience from UK.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cyclophosph | 2021 |
An in vitro cytotoxicity of glufosfamide in HepG2 cells relative to its nonconjugated counterpart.
Topics: Glucose; Hep G2 Cells; Humans; Ifosfamide; Liver Neoplasms | 2021 |
Disease-free survival after radical resection followed by adjuvant chemotherapy for primary hepatic synovial sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Epirubicin; Hepatectomy; Hum | 2018 |
Primary hepatic carcinosarcoma with multimodal treatment.
Topics: Aged; Antibiotics, Antineoplastic; Carcinosarcoma; Combined Modality Therapy; Doxorubicin; Humans; I | 2018 |
Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report.
Topics: Antineoplastic Agents; Biopsy; Child, Preschool; Docetaxel; Doxorubicin; Female; Hemangiosarcoma; Hu | 2019 |
The effect of ifosfamide, epirubicin, and recombinant human endostatin therapy on a cardiac angiosarcoma: A case report.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Endostatins; Epirubicin; Hear | 2019 |
Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; D | 2020 |
PEComa of the colon resistant to sirolimus but responsive to doxorubicin/ifosfamide.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Chemotherapy, A | 2013 |
Embryonal sarcoma of the liver.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chil | 2013 |
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxol | 2016 |
Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Ci | 2016 |
Childhood undifferentiated embryonal liver sarcoma: clinical features and immunohistochemistry analysis.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protoc | 2008 |
Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplas | 2008 |
Long-term disease stabilization during second-line gemcitabine in a refractory metastatic haemangioendothelioma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplas | 2009 |
Desmoplastic small round cell tumor in children: a new therapeutic approach.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Ca | 2009 |
[Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Etoposide; Fem | 2009 |
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Doxorubicin; Etoposide; Humans; Ifosfamide; | 2010 |
Hepatosplenic alphabeta T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Transplantation; Carbopla | 2010 |
Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Drug Administration Sch | 2011 |
Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Com | 2011 |
The first case of primary testicular germ cell tumor containing nephroblastoma as the only one non-germ cell component.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cisplatin; | 2011 |
A case of undifferentiated embryonic liver sarcoma mimicking cystic hydatid disease in an endemic region of the world.
Topics: Abdominal Pain; Albendazole; Anthelmintics; Antineoplastic Combined Chemotherapy Protocols; Carbopla | 2011 |
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Humans; Ifosfamid | 2012 |
Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamo | 2012 |
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomyci | 2013 |
The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali | 2002 |
Use of sarcoma-based chemotherapy in a case of congenital mesoblastic nephroma with liver metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; | 2003 |
[A difficult case of advanced testicular choriocarcinoma effectively treated by chemotherapy and resection of lung metastasis].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Choriocarcinoma | 2004 |
Management of hepatic epithelioid haemangio-endothelioma in children: what option?
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child | 2004 |
Enzyme activity analysis of CYP2C18 with exon 5 skipped.
Topics: Alternative Splicing; Aryl Hydrocarbon Hydroxylases; Carcinoma, Hepatocellular; Cell Line, Tumor; Ce | 2004 |
Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fat | 2006 |
Unresectable multifocal hepatoblastoma with cardiac extension: excellent response with HB-94 chemotherapy protocol.
Topics: alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcinosi | 2006 |
Durable and complete remission of a metastatic bladder sarcomatoid carcinoma with chemotherapic and surgical treatments.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; | 2006 |
A case of metastatic testicular cancer complicated by tumour lysis syndrome and choriocarcinoma syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Cisplatin; Drug A | 2006 |
[Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; F | 2006 |
[A non-seminomatous extra-gonadal germ cell tumor responding to intensive treatment: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2006 |
[A case of the treatment in an adult with hepatic undifferentiated (embryonal) sarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamid | 2007 |
[Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemothe | 2007 |
Primary hepatic Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2008 |
[Toxic-allergic lung edema following cyclophosphamide and ifosfamide therapy. Case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin | 1983 |
Successful liver treatment of a juvenile granulosa cell tumor in a 4-year-old child by regional deep hyperthermia, systemic chemotherapy, and irradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child, Preschoo | 1995 |
Undifferentiated (embryonal) sarcoma of the liver in an adult patient with metastasis of the heart and brain.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; E | 1994 |
Long-term disease-free survival in a child with refractory metastatic malignant germ cell tumor treated by high-dose chemotherapy with autologous bone marrow rescues.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Cisplat | 1994 |
Primary extracranial rhabdoid tumors. Clinicopathologic features and response to ifosfamide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Chil | 1993 |
Hepatic angiosarcoma in a child: successful therapy with surgery and adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; | 1997 |
Prolonged survival in a nasopharyngeal carcinoma patient with multiple metastases: a case report and review of the literature.
Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 1997 |
Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin, and etoposide in heterotransplanted hepatoblastoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Carboplatin; Cell Division; Child, Preschool; Ci | 1998 |
[Primary leiomyosarcoma of the kidney. A case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Female; Humans; Ifosfamide; Kidn | 1999 |
[A case of metastatic liver tumors from prostatic cancer responding to intra-arterial infusion chemotherapy with CDDP and ifosfamide using implantable port].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasm | 1999 |
[A case of advanced retroperitoneal dedifferentiated liposarcoma treated effectively with high-dose ifosfamide].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Combined Modality | 1999 |
High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoid Tumor; Cisplatin; E | 2000 |
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Dose-Response | 2001 |
Cure in a case of primary hepatic lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hum | 2000 |
Chemotherapy for hepatic angiosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Doxorubicin; Hemangiosarcoma; Hu | 1992 |
A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Carcinoma, | 1991 |
Combination chemotherapy in the treatment of hepatoblastoma.
Topics: Adenomatous Polyposis Coli; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biom | 1990 |
Ifosfamide, methotrexate and 5-fluorouracil for pretreated advanced breast cancer.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 1991 |
[Clinical efficacy of ifosfamide for liver metastasis of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Breast Neoplasms; Doxorubicin; Drug Ad | 1990 |
Bulky germinal tumors: comparison of different induction regimens and significance of residual disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Humans; Ifosfamid | 1985 |
Phase II study of ifosfamide (Holoxan) in hepatoma.
Topics: Adult; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Live | 1988 |
A phase II study of high dose ifosfamide in metastatic colorectal cancer.
Topics: Adult; Aged; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Ifosfamide; Liver Neoplasms; Lun | 1989 |